DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 2150--------------------------------------------------
       (Abst.) Drug-associated PML in MS patients
       By: agate Date: July 17, 2018, 6:21 pm
       ---------------------------------------------------------
       From Multiple Sclerosis Journal, July 9, 2018--"Drug-associated
       progressive multifocal leukoencephalopathy in multiple sclerosis
       patients," a study of more than 100,000 MS patients over two
       years (2015-17).  The researchers conclude:
       [quote][font=arial]The relative risk of PML with natalizumab was
       much higher than with any of the other DMDs and one with
       fingolimod followed. One with dimethyl fumarate and rituximab
       was lesser. Glatiramer acetate, interferon, and dalfampridine
       were not associated with PML risk based on our analysis.[/font]
       [/quote]
  HTML http://journals.sagepub.com/doi/abs/10.1177/1352458518786075
       *****************************************************